ACS Washington 2009: Energy of the nearer future?
This year ACS hosted a two-day symposium on the National Ignition Facility and a couple of the other big nuclear fusion efforts. Given the audience, most of the talks focused on the role chemists could play in diagnostics, i.e. detecting whether fusion actually occurs, and on the different sorts of experiments chemists might be interested in, like nucleosynthesis and stellar burning processes.
NIF has had its share of delays, dilemmas and scandals, but finished construction in late March and looks to make its first attempts at ignition next year. At the conference, NIF science director Richard Boyd said they're currently running experimental implosions — up to two a day — to optimize all the parameters, and using “a bunch of tricks to make the process as efficient as possible”. For example, right now none of the experimental implosions are using deuterium-tritium targets, but Boyd notes that “with just a tiny bit of deuterium, we can actually go through most of the optimization procedures without producing neutrons, which are problematic because they activate things”.
Continue reading "ACS Washington 2009: Energy of the nearer future?" »

It's the second to last day of the conference and the chemists are starting to head home. The hallways are quieter, the rooms less full, the Metro less forested by rolled up posters, the Power Bar options in the press room more limited. So I decided to give myself a little treat today: biological chemistry. As a life scientist by training, I've been rather out of my element the past week.
Today I started with a talk by Jack Szostak from Massachusetts General Hospital and Harvard. I'd originally heard of Szostak because he co-discovered telomerase, but discovered he was no one-trick pony when he was name-dropped all over last week's NSF
This morning at the conference, Charles Arntzen from Arizona State University talked about transforming plants into little green vaccine-manufacturing machines using engineered viruses. He helped pioneer the technique a few years ago when he made a vaccine 
In the spirit of our swampy environs, the first press conference Sunday morning was on the special anti-microbial/fungal/viral properties of alligator blood. Biochemist and alligator rassler Mark Merchant of McNeese State University in southwestern Louisiana wasn't on hand to field questions, but two of his colleagues filled in, describing some progress on testing the blood's ability to kill microscopic invaders